New Medicines Globally
Medicine access. For everyone.
We are a registered as an international pharmacy and are experts in medicine access. No matter who you are or where you live, we will guide you and your physician to safely and legally access a prescription medicine that is not yet approved or available in your country.
Thousands of patients helped with information and access from 175 countries. Let us help you.
We have received enquiries from patients from all over the world. View our live map to see the countries we have supported with information and access to date.
Latest approved medicines available.
Non-small Cell Lung Cancer (NSCLC) |Augtyro (repotrectinib) by Bristol-Myers Squibb - Approved by the FDA in November 2023.
Congenital Thrombotic Thrombocytopenic Purpura |Adzynma (ADAMTS13, recombinant-krhn) by Takeda Pharma - Approved by the FDA in November 2023.
Colorectal Cancer |Fruzaqla (fruquintinib) by Takeda Pharma - Approved by the FDA in November 2023.
Rheumatoid Arthritis |Tofidence (tocilizumab-bavi) by Biogen - Approved by the FDA in September 2023.
Pompe Disease |Pombiliti (cipaglucosidase alfa-atga) by Amicus Therapeutics - Approved by the FDA, EMA in September 2023.
Alzheimer's Disease |Leqembi (lecanemab-irmb) by Eisai Europe Ltd - Approved by the FDA in January 2023.